-
Je něco špatně v tomto záznamu ?
Molecular targets in cancer therapy and their impact on cancer management : 2nd state-of-the-art conference : Montreux, Switzerland, February 23-24, 2002
guest editor Axel Ullrich
- Publikováno
- Basel : Karger, 2002
- Edice
- Oncology, ISSN 0030-2414 vol. 63, suppl. 1, November 2002
- Stránkování
- 63 s. : tab., grafy ; 30 cm
Jazyk angličtina Země Švýcarsko
Typ dokumentu kongresy
Knihovny.cz ISBN
3-8055-7502-5
- MeSH
- genetická terapie MeSH
- lékové transportní systémy MeSH
- monoklonální protilátky MeSH
- nádory terapie MeSH
- tyrosinkinasové receptory MeSH
- tyrosinkinasy antagonisté a inhibitory MeSH
- Publikační typ
- kongresy MeSH
- Konspekt
- Patologie. Klinická medicína
- NLK Obory
- onkologie
- biologie
Although experimental and clinical cancer research need to be closely linked, advances at the basic level often remain remote from medical application. This journal works to accelerate the translation of experimental results to the clinic. In each issue, findings from basic research are integrated with currrent theoretical knowledge and discussed in terms of their relevance to the detection and treatment of cancer. Significant clinical studies from cancer centers around the world are included, supplemented by occasional case studies and reviews. Although experimental and clinical cancer research need to be closely linked, advances at the basic level often remain remote from medical application. This journal works to accelerate the translation of experimental results to the clinic. In each issue, findings from basic research are integrated with currrent theoretical knowledge and discussed in terms of their relevance to the detection and treatment of cancer. Significant clinical studies from cancer centers around the world are included, supplemented by occasional case studies and reviews.
Oncology : International journal of cancer research and treatment.
Skrytá bibl.
Bibliografie atd.Autorský a věcný rejstřík
Vlastník | Detaily | Služby | |||||
---|---|---|---|---|---|---|---|
NLK | NLK 2002 Signatura A 1015/63-S.1-2002 [1] | ||||||
Nahrávání dat ...
|
- 000
- 01768nam 2200469 a 4500
- 001
- MED00117090
- 003
- CZ-PrNML
- 005
- 20200330103339.0
- 008
- 041122s2002 sz eng||
- 009
- BK
- 020 __
- $a 3-8055-7502-5 $q (brož.)
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz $c CH
- 072 _7
- $x Patologie. Klinická medicína $a 616 $2 konspekt $7 sk136316
- 080 __
- $a 616-006 $2 h
- 080 __
- $a 576.32/.36 $2 h
- 080 __
- $a 577 $2 h
- 245 00
- $a Molecular targets in cancer therapy and their impact on cancer management : $b 2nd state-of-the-art conference : Montreux, Switzerland, February 23-24, 2002 / $c guest editor Axel Ullrich
- 260 __
- $a Basel : $b Karger, $c 2002
- 300 __
- $a 63 s. : $b tab., grafy ; $c 30 cm
- 490 1_
- $a Oncology, $x 0030-2414 ; $v vol. 63, suppl. 1, November 2002
- 504 __
- $a Skrytá bibl.
- 504 __
- $a Autorský a věcný rejstřík
- 650 07
- $a nádory $x terapie $2 czmesh $7 D009369
- 650 07
- $a lékové transportní systémy $2 czmesh $7 D016503
- 650 07
- $a genetická terapie $2 czmesh $7 D015316
- 650 07
- $a tyrosinkinasy $x antagonisté a inhibitory $2 czmesh $7 D011505
- 650 07
- $a monoklonální protilátky $2 czmesh $7 D000911
- 650 07
- $a tyrosinkinasové receptory $2 czmesh $7 D020794
- 650 07
- $a onkologie $2 mednas $7 nlk20040148136
- 650 07
- $a biologie $2 mednas $7 nlk20040147082
- 655 _7
- $a kongresy $2 czmesh $7 D016423
- 700 1_
- $a Ullrich, Axel $4 edt $7 _gn020042997
- 772 0_
- $w MED00010344 $t Oncology $x 0030-2414
- 830 _0
- $a Oncology, $x 0030-2414
- 910 __
- $a ABA008 $b A 1015/63-S.1-2002 $y x
- 990 __
- $a 20041122 $b ABA008
- 991 __
- $a 20200330103811 $b ABA008
- BAS __
- $a NML $a 02 $a 30 $a 12
- LKV __
- $a MED00003601 $b 2002 63 Suppl. 1 $d 132276
- LZP __
- $b 50